Need professional-grade analysis? Visit stockanalysis.com
$345.59M
8.50
261
1.18%
Sinco Pharms Hldg Ltd (6833) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at HKD0.17, down 3.35% from the previous close.
Over the past year, 6833 has traded between a low of HKD0.16 and a high of HKD0.27. The stock has lost 1.7% over this period. It is currently 35.9% below its 52-week high.
Sinco Pharms Hldg Ltd has a market capitalization of $345.59M, with a price-to-earnings ratio of 8.50 and a dividend yield of 1.18%.
Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, soft tissue infections, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for the prevention of post-surgery infections; and Medocef that is used for the treatment of bacterial infections, including infections of the lower respiratory tract, such as pneumonia, urinary tract, bile duct, peritoneum, skin, soft tissue, pelvic area, and sepsis. The company also provides Esafosfina, which is used for treating hypophosphatemia and chronic diseases comprising alcohol intoxication, malnutrition, and hypophosphatemic respiratory failure; Taurolite, an oral cholic acid drug that is used for the treatment of gallstone diseases or cholelithiasis; and Tamifil injection for the treatment of metastatic prostate cancer, true precocious puberty, and endometriosis. In addition, it is involved in the research, development, and sale of pharmaceutical products; provision of warehouse facilities for pharmaceutical products; research and manufacturing of aesthetic medicine; international trade activities; consultation services for medical and biological technology; market promotion; and medical beauty services. The company was founded in 2011 and is headquartered in Chengdu, the People's Republic of China. Sinco Pharmaceuticals Holdings Limited is a subsidiary of Risun Investments Limited.
Side-by-side comparison against top Healthcare peers.